VSTMVerastem, Inc.

$10.02+27% 1Y

Is the price fair?

What VSTM's price assumes

Verastem, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 4.37× revenue.

4.37

Price / sales · no P/E: the last twelve months did not end in a profit

Price / book
7.65

Price / book · as of 2026-Q2

EV / sales
2.81

EV / sales

Details›
Price / bookas of 2026-Q2
7.65
EV / EBIToperating margin −183%: the multiple describes the denominator
not meaningful
EV / salesas of 2026-Q2
2.81
Market capitalisation90.6 million shares, counted Aug 3, 2026
$907M

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.